XML 33 R23.htm IDEA: XBRL DOCUMENT
v3.21.4

Note 16 - Derivatives | 6 Months Ended
--- | ---
Oct. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Note 16 - Derivatives | Note 16 - Derivatives The Company completed financings in October 2020 and January 2021 which included notes and warrants containing embedded features subject to derivative accounting. See Note 10 for a full description of these financings. Both the notes and the warrants included provisions which provided for a reduction in the conversion and exercise prices, respectively, if the Company completed a future qualified offering at a lower price. These provisions represent embedded derivatives which are valued separately from the host instrument (meaning the notes and warrants) and recognized as derivative liabilities on the Company's balance sheet. The Company initially measures these financial instruments at their estimated fair value and recognizes changes in their estimated fair value in results of operations during the period of change. The Company also measures these financial instruments on the date of settlement (meaning when the note is converted or the warrant is exercised) at their estimated fair value and recognizes changes in their estimated fair value in results of operations. Any discount in the carrying value of the note is fully amortized on the date of settlement and recognized as interest expense. The Company estimated the fair value of these embedded derivatives using a multinomial lattice mode1. The range of underlying assumptions used in the binomial model to determine the fair value of the derivative warrant liability upon settlement of the derivative liability and as of October 31, 2021 are set forth below. In addition, the Company's stock price on each measurement date was used in the model.
Risk-free interest rate |  |  | 0.75 - 0.97% |
Expected dividend yield |  |  | — |
Expected term (in years) |  |  | 3.92 - 4.24 |
Expected volatility |  |  | 272.54 – 292.28% |
As of October 31, 2021, all of the notes had been converted into common stock and 806,666 of the warrants were outstanding. Changes in the derivative liability during the three and six months ended October 31, 2021 were as follows:
Derivative liability at April 30, 2021 |  | $ | 2,812,767 |
Eliminated upon exercise of warrants |  |  | (163,141 | )
Changes in fair value, primarily related to decrease in Company's stock price |  |  | (154,248 | )
Derivative liability at July 31, 2021 |  | $ | 2,495,378 |
Eliminated upon exercise of warrants |  |  | — |
Changes in fair value, primarily related to decrease in Company's stock price |  |  | (118,813 | )
Derivative liability at October 31, 2021 |  | $ | 2,376,565 |

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI http://asc.fasb.org/topic&trid=2229140 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 5 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration